5-(4-Hydroxy-3-methoxyphenyl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione, 95.0%, 1g

2-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)-3,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one, 95.0%, 500mg

2-Chlorobenzamide, 95.0%, 500g

3-(3-Trifluoromethyl-phenyl)-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester, 95.0%, 25g

(4-BROMOPHENYL)(CYCLOPROPYL)METHANAMINE HCL, 95.0%, 1g

Receptor de vacío recto, 24/29, 24/29, 1 pieza

5-(4-Isopropylphenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 25g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96.0%, 1g

(2S)-2-[(tert-butoxycarbonyl)amino]-4-(9H-fluoren-9-ylmethoxy)-4-oxobutanoic acid, 98%, 5g

H-Asn-OtBu HCl, 95.0%, 1g

2-Chloro-5-iodotoluene, 95.0%, 500g

4-Methyl-1H-indole-6-carboxylic acid, 97.0%, 250mg

4,4,4-Trifluoro-1-butanol>98.0%(GC)1g